Copyright
©2012 Baishideng.
World J Gastrointest Endosc. Sep 16, 2012; 4(9): 409-413
Published online Sep 16, 2012. doi: 10.4253/wjge.v4.i9.409
Published online Sep 16, 2012. doi: 10.4253/wjge.v4.i9.409
Table 3 The incidence of each stage in each group (Antiplatelet and control group) and the comparison between the two groups n (%)
| Antiplatelet group (n = 98) | Control group (n = 289) | P value | |
| Stage I (1) | 24 (24.4) | 47 (16.2) | 0.0721 |
| Stage II (2) | 32 (32.6) | 79 (27.3) | 0.3656 |
| Stage III (3) | 34 (34.6) | 114 (39.3) | 0.4707 |
| Stage IV (4) | 8 (8.1) | 49 (16.9) | 0.033 |
- Citation: Symeonidis D, Koukoulis G, Christodoulidis G, Mamaloudis I, Chatzinikolaou I, Tepetes K. Impact of antiplatelet treatment on colorectal cancer staging characteristics. World J Gastrointest Endosc 2012; 4(9): 409-413
- URL: https://www.wjgnet.com/1948-5190/full/v4/i9/409.htm
- DOI: https://dx.doi.org/10.4253/wjge.v4.i9.409